Application of biomimetic HPLC to estimate lipophilicity, protein and phospholipid binding of potential peptide therapeutics
K Valko, G Ivanova-Berndt, P Beswick, M Kindey… - ADMET and …, 2018 - hrcak.srce.hr
Sažetak Peptide therapeutics are new modalities offering several challenges to drug
discovery. They are generally less stable and permeable in vivo. The characterization of …
discovery. They are generally less stable and permeable in vivo. The characterization of …
[PDF][PDF] Application of biomimetic HPLC to estimate lipophilicity, protein and phospholipid binding of potential peptide
K Valko, G Ivanova-Berndt, P Beswick, M Kindey, D Ko - scholar.archive.org
Peptide therapeutics are new modalities offering several challenges to drug discovery. They
are generally less stable and permeable in vivo. The characterization of their lipophilicity …
are generally less stable and permeable in vivo. The characterization of their lipophilicity …
[PDF][PDF] Application of biomimetic HPLC to estimate lipophilicity, protein and phospholipid binding of potential peptide
K Valko, G Ivanova-Berndt, P Beswick, M Kindey, D Ko - pdfs.semanticscholar.org
Peptide therapeutics are new modalities offering several challenges to drug discovery. They
are generally less stable and permeable in vivo. The characterization of their lipophilicity …
are generally less stable and permeable in vivo. The characterization of their lipophilicity …
Application of biomimetic HPLC to estimate lipophilicity, protein and phospholipid binding of potential peptide therapeutics
K Valko, G Ivanova-Berndt, P Beswick, M Kindey… - ADMET and …, 2018 - hrcak.srce.hr
Sažetak Peptide therapeutics are new modalities offering several challenges to drug
discovery. They are generally less stable and permeable in vivo. The characterization of …
discovery. They are generally less stable and permeable in vivo. The characterization of …
[PDF][PDF] Application of biomimetic HPLC to estimate lipophilicity, protein and phospholipid binding of potential peptide
K Valko, G Ivanova-Berndt, P Beswick, M Kindey, D Ko - academia.edu
Peptide therapeutics are new modalities offering several challenges to drug discovery. They
are generally less stable and permeable in vivo. The characterization of their lipophilicity …
are generally less stable and permeable in vivo. The characterization of their lipophilicity …
[PDF][PDF] Application of biomimetic HPLC to estimate lipophilicity, protein and phospholipid binding of potential peptide
K Valko, G Ivanova-Berndt, P Beswick, M Kindey, D Ko - bicycletherapeutics.com
Peptide therapeutics are new modalities offering several challenges to drug discovery. They
are generally less stable and permeable in vivo. The characterization of their lipophilicity …
are generally less stable and permeable in vivo. The characterization of their lipophilicity …
Application of biomimetic HPLC to estimate lipophilicity, protein and phospholipid binding of potential peptide therapeutics
KL Valko, G Ivanova-Berndt, P Beswick… - ADMET and …, 2018 - pub.iapchem.org
Peptide therapeutics are new modalities offering several challenges to drug discovery. They
are generally less stable and permeable in vivo. The characterization of their lipophilicity …
are generally less stable and permeable in vivo. The characterization of their lipophilicity …
[PDF][PDF] Application of biomimetic HPLC to estimate lipophilicity, protein and phospholipid binding of potential peptide
K Valko, G Ivanova-Berndt, P Beswick, M Kindey, D Ko - bicycletherapeutics.com
Peptide therapeutics are new modalities offering several challenges to drug discovery. They
are generally less stable and permeable in vivo. The characterization of their lipophilicity …
are generally less stable and permeable in vivo. The characterization of their lipophilicity …
[PDF][PDF] Application of biomimetic HPLC to estimate lipophilicity, protein and phospholipid binding of potential peptide
K Valko, G Ivanova-Berndt, P Beswick, M Kindey, D Ko - scholar.archive.org
Peptide therapeutics are new modalities offering several challenges to drug discovery. They
are generally less stable and permeable in vivo. The characterization of their lipophilicity …
are generally less stable and permeable in vivo. The characterization of their lipophilicity …